Evidence map›Paper›PMID 23018120›Full record

ArticleEmerging infectious diseases2012

Scarlet fever epidemic, Hong Kong, 2011.

Emma Y Y Luk, Janice Y C Lo, Amy Z L Li, Michael C K Lau, Terence K M Cheung, Alice Y M Wong, Monica M H Wong, Christine W Wong, Shuk-kwan Chuang, Thomas Tsang

Abstract read
In one paragraph

Article in Emerging infectious diseases, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 28 papers.

0numbers the graph read from it
0cells of the map it votes in
28citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

28 citing papers in PubMed.

  1. Article
  2. Epidemiological Characteristics and Trends of Scarlet Fever in Zhejiang Province of China: Population-Based Surveillance during 2004-2022.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2024
    Article
  3. Review
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Analysis of Epidemiological Characteristics of Scarlet Fever in Zhejiang Province, China, 2004-2018.International journal of environmental research and public health · 2019
    Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Review
  15. Article
  16. Article
  17. The Comeback of Scarlet Fever.EBioMedicine · 2018
    Article
  18. Article
  19. Immunogenicity and Safety of a Chemically Synthesized Divalent Group A Streptococcal Vaccine.The Canadian journal of infectious diseases & medical microbiology = Journal canadien des maladies infectieuses et de la microbiologie medicale · 2018
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Emma Y Y LukCentre for Health Protection, Hong Kong, People’s Republic of China. mo_fetp2@dh.gov.hk
Janice Y C Lo
Amy Z L Li
Michael C K Lau
Terence K M Cheung
Alice Y M Wong
Monica M H Wong
Christine W Wong
Shuk-kwan Chuang
Thomas Tsang

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

More than 900 cases of scarlet fever were recorded in Hong Kong during January-July, 2011. Six cases were complicated by toxic shock syndrome, of which 2 were fatal. Pulsed-field gel electrophoresis patterns suggested a multiclonal epidemic; emm12 was the predominant circulating type. We recommend genetic testing of and antimicrobial resistance monitoring for this reportable disease.

Indexed as

EpidemicsAnti-Bacterial AgentsChildElectrophoresis, Gel, Pulsed-FieldFemaleHong KongHumansIncidenceMicrobial Sensitivity TestsScarlet FeverShock, SepticStreptococcus pyogenesAnti-Bacterial Agents

Identifiers

PMID23018120
PMCPMC3471614

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.